These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7760040)

  • 21. Role of tryptophan in the elevated serotonin-turnover in hepatic encephalopathy.
    Herneth AM; Steindl P; Ferenci P; Roth E; Hörtnagl H
    J Neural Transm (Vienna); 1998; 105(8-9):975-86. PubMed ID: 9869330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
    Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3,4-dioxygenase inhibitor NCR-631.
    Fornstedt-Wallin B; Lundström J; Fredriksson G; Schwarcz R; Luthman J
    Eur J Pharmacol; 1999 Dec; 386(1):15-24. PubMed ID: 10611459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
    Zeneroli ML
    J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists.
    Yurdaydin C; Herneth AM; Püspök A; Steindl P; Singer E; Ferenci P
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):667-71. PubMed ID: 8853256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.
    Chu CJ; Hsiao CC; Wang TF; Chan CY; Lee FY; Chang FY; Chen YC; Huang HC; Wang SS; Lee SD
    World J Gastroenterol; 2005 Jan; 11(2):232-6. PubMed ID: 15633222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
    Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain.
    Heyes MP; Saito K; Jacobowitz D; Markey SP; Takikawa O; Vickers JH
    FASEB J; 1992 Aug; 6(11):2977-89. PubMed ID: 1322853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.
    Avraham Y; Grigoriadis N; Poutahidis T; Vorobiev L; Magen I; Ilan Y; Mechoulam R; Berry E
    Br J Pharmacol; 2011 Apr; 162(7):1650-8. PubMed ID: 21182490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophan.
    Bergqvist PB; Carpenedo R; Apelqvist G; Moroni F; Bengtsson F
    Pharmacol Toxicol; 1999 Sep; 85(3):138-43. PubMed ID: 10522754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolinate in brain and cerebrospinal fluid in rat models of congenital hyperammonemia.
    Robinson MB; Heyes MP; Anegawa NJ; Gorry E; Djali S; Mellits ED; Batshaw ML
    Pediatr Res; 1992 Oct; 32(4):483-8. PubMed ID: 1279510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.
    Heyes MP; Saito K; Lackner A; Wiley CA; Achim CL; Markey SP
    FASEB J; 1998 Jul; 12(10):881-96. PubMed ID: 9657528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in kynurenic, anthranilic, and quinolinic acid concentrations in rat brain tissue during development.
    Cannazza G; Chiarugi A; Parenti C; Zanoli P; Baraldi M
    Neurochem Res; 2001 May; 26(5):511-4. PubMed ID: 11513477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and brain uptake of gamma-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats.
    Zeneroli ML; Iuliano E; Racagni G; Baraldi M
    J Neurochem; 1982 May; 38(5):1219-22. PubMed ID: 7062047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
    He X; Luan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):45-8. PubMed ID: 1398623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of mitochondria and o-methoxybenzoylalanine on 3-hydroxyanthranilic acid dioxygenase activity and quinolinic acid synthesis.
    Chiarugi A; Moroni F
    J Neurochem; 1999 Mar; 72(3):1125-32. PubMed ID: 10037484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of hepatic nitric oxide synthases in rats with thioacetamide-induced acute liver failure and encephalopathy.
    Huang HC; Wang SS; Chan CY; Chen YC; Lee FY; Chang FY; Chu CJ; Lin HC; Lu RH; Lee SD
    J Chin Med Assoc; 2007 Jan; 70(1):16-23. PubMed ID: 17276928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand.
    Basile AS; Gammal SH; Jones EA; Skolnick P
    J Neurochem; 1989 Oct; 53(4):1057-63. PubMed ID: 2549194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary protein level and dietary interaction affect quinolinic acid concentration in rats.
    Egashira Y; Sato M; Saito K; Sanada H
    Int J Vitam Nutr Res; 2007 Mar; 77(2):142-8. PubMed ID: 17896587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis.
    Lahdou I; Sadeghi M; Oweira H; Fusch G; Daniel V; Mehrabi A; Jung G; Elhadedy H; Schmidt J; Sandra-Petrescu F; Iancu M; Opelz G; Terness P; Schefold JC
    Hum Immunol; 2013 Jan; 74(1):60-6. PubMed ID: 23046794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.